Get started
NUREXONE BIOLOGIC INCNUREXONE BIOLOGIC INCNUREXONE BIOLOGIC INC

NUREXONE BIOLOGIC INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

NRX chart


Full chart

NRX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪37.95 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.10 CAD
Net income (FY)
‪−4.91 M‬ CAD
Revenue (FY)
0.00 CAD
Shares float
‪51.07 M‬
Beta (1Y)
0.06

Employees


Employees (FY)
17
Change (1Y)
+1 +6.25%
Revenue / Employee (1Y)
0.00 CAD
Net income / Employee (1Y)
‪−288.91 K‬ CAD

About NUREXONE BIOLOGIC INC


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Lior Shaltiel
Website
nurexone.com
Headquarters
Bnei-Brak
Founded
2011
FIGI
BBG002CV5Z73
NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Bnei-Brak, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NRX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as NRX.

Frequently Asked Questions


The current price of NRX is 0.67 CAD — it has decreased by −1.47% in the past 24 hours. Watch NUREXONE BIOLOGIC INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange NUREXONE BIOLOGIC INC stocks are traded under the ticker NRX.
NRX stock has fallen by −2.90% compared to the previous week, the month change is a 19.64% rise, over the last year NUREXONE BIOLOGIC INC has showed a −9.46% decrease.
We've gathered analysts' opinions on NUREXONE BIOLOGIC INC future price: according to them, NRX price has a max estimate of 3.04 CAD and a min estimate of 3.04 CAD. Watch NRX chart and read a more detailed NUREXONE BIOLOGIC INC stock forecast: see what analysts think of NUREXONE BIOLOGIC INC and suggest that you do with its stocks.
NRX reached its all-time high on Feb 20, 2024 with the price of 1.19 CAD, and its all-time low was 0.10 CAD and was reached on Apr 14, 2023. View more price dynamics on NRX chart.
See other stocks reaching their highest and lowest prices.
NRX stock is 1.49% volatile and has beta coefficient of 0.06. Track NUREXONE BIOLOGIC INC stock price on the chart and check out the list of the most volatile stocks — is NUREXONE BIOLOGIC INC there?
Today NUREXONE BIOLOGIC INC has the market capitalization of ‪37.95 M‬, it has decreased by −5.56% over the last week.
Yes, you can track NUREXONE BIOLOGIC INC financials in yearly and quarterly reports right on TradingView.
NUREXONE BIOLOGIC INC is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
NRX earnings for the last quarter are −0.03 CAD per share, whereas the estimation was −0.03 CAD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.03 CAD per share. See more details about NUREXONE BIOLOGIC INC earnings.
NUREXONE BIOLOGIC INC revenue for the last quarter amounts to 0.00 CAD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
NRX net income for the last quarter is ‪−1.70 M‬ CAD, while the quarter before that showed ‪−1.81 M‬ CAD of net income which accounts for 5.96% change. Track more NUREXONE BIOLOGIC INC financial stats to get the full picture.
No, NRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 2, 2025, the company has 17 employees. See our rating of the largest employees — is NUREXONE BIOLOGIC INC on this list?
Like other stocks, NRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NUREXONE BIOLOGIC INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NUREXONE BIOLOGIC INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NUREXONE BIOLOGIC INC stock shows the buy signal. See more of NUREXONE BIOLOGIC INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.